TGF - β Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Regulation of Angiogenesis and Blood Supply
Pulmonary Hypertension: Classification and Pathogenesis
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Hedgehog Signaling Pathway
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 25, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Jie Zeng1, Dengyuan Li1, Jun Wang2
1Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, China (J.Z., D.L., R.W., Z.H., D.S., R.L., Y.Z.).
Thrombospondin-4 (THBS4) is elevated in pulmonary hypertension and drives vascular remodeling. Silencing THBS4 reduced pulmonary vascular remodeling and right ventricular hypertrophy, suggesting THBS4 as a therapeutic target.
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: